Administering the optimum dose of l-arginine in regional tumor therapy

Indian Journal of Clinical Biochemistry

Volumn 29, Issue 4, 2014, Pages 442-451

  Moawad, Emad Y ^a,b  

^a Ain Shams University   (Egypt)

^b NONE   (Egypt)

Author keywords

3H thymidine based cell proliferation assay; 51Chromium release assay; Cell membrane damage; Emad formula; Histologic grade; Stimulating apoptosis

Indexed keywords

ARGININE; CHROMIUM 51; PHOSPHATE BUFFERED SALINE; THYMIDINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FIBROSARCOMA; FIBROSARCOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOSARCOMA; LYMPHOSARCOMA CELL LINE; NONHUMAN; OPTIMAL DRUG DOSE; SURVIVAL RATE; SURVIVAL TIME;

EID: 84907591656     PISSN: 09701915     EISSN: 09740422     Source Type: Journal    
DOI: 10.1007/s12291-013-0379-z     Document Type: Article

References (21)

1. Tapiero H, Mathé G, Couvreur P, Tew KD. l-Arginine. Biomed Pharmacother. 2002;56(9):439-45 REVIEW. PMID 12481980.
2. Stechmiller JK, Childress B, Cowan L. Arginine supplementation and wound healing. Nutr Clin Pract. 2005;20(13):52-61 REVIEW. PMID 16207646.
3. Witte MB, Barbul A. Arginine physiology and its implication for wound healing. Wound Repair Regen. 2003;11(6):419-23 REVIEW. PMID 14617280.
4. Yurtcu E, Kasapoglu E, Sahin F. Protective effects of β-carotene and silymarin on human lymphocytes. Turk J Biol. 2012;36:47-52.
5. El-Missiry MA, Othman AI, Amer MA. l-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus. J Appl Toxicol. 2004;24(2):93-7.
6. Lin WT, Yang SC, Chen KT, Huang CC, Lee NY. Protective effects of l-arginine on pulmonary oxidative stress and antioxidant defenses during exhaustive exercise in rats. Acta Pharmacol Sin. 2005;26:992-9.
7. Nanthakumaran S, Brown I, Steven DH, Schofield AC. Inhibition of gastric cancer cell growth by arginine: molecular mechanisms of action. Clin Nutr. 2009;28:65-70.
8. Wolf C, Bruss M, Hanisch B, Gothert M, von Kugelgen I, Molderings GJ. Molecular basis for the antiproliferative effect of agmatine in tumor cells of colonic, hepatic, and neuronal origin. Mol Pharmacol. 2007;71:276-83.
9. Lemeshko VV. Potential-dependent membrane permeabilization and mitochondrial aggregation caused by anticancer polyarginine-KLA peptides. Arch Biochem Biophys. 2010;493:213-20.
10. Moawad EY. Clinical and pathological staging of the cancer at the nanoscale. Cancer Nano. 2012;3:37-46.
11. Moawad EY. Reconciliation between the clinical and pathological staging of cancer. Comp Clin Pathol. 2012. doi: 10.1007/s00580-012-1603-6.
12. Moawad E. Isolated system towards a successful radiotherapy treatment. Nucl Med Mol Imaging. 2010;44:123-36.
13. Moawad EY. Radiotherapy and risks of tumor regrowth or inducing second cancer. Cancer Nano. 2011;2:81-93.
14. Moawad EY. Optimizing bioethanol production through regulating yeast growth energy. Syst Synth Biol. 2012;6:61-8.
15. Moawad EY. Safe doses and cancer treatment evaluation. Cancer Oncol Res. 2013;1:6-11. doi: 10.13189/cor.2013.010102.
16. Shukla J, Thakur VS, Poduval TB. Arginine: appropriate dose and delivery environment makes it an anticancer molecule. Open Cancer J. 2010;3:1-15.
17. Thakur VS, Shankar B, Chatterjee S, Premachandran S, Sainis KB. Role of tumor-derived transforming growth factor-β1 (TGF-β1) in site-dependent tumorigenicity of murine ascitic lymphosarcoma. Cancer Immunol Immunother. 2005;54:837-47.
18. Poduval TB, Seshadri M, Sundaram K. Lectin potentiation of BCG-contact-mediated antitumor action. J Natl Cancer Inst (Bethesda). 1984;65:909-12.
19. Barbalace K. Periodic table of elements - H - hydrogen. 1995-2011. http://environmentalchemistry.com/yogi/periodic/H-pg2.html. Accessed online: 21 Dec 2011.
20. Lu W, Schroit AJ. Vascularization of melanoma by mobilization and remodeling of preexisting latent vessels to patency. Cancer Res. 2005;65:913-8.
21. Thyrell L, Erickson S, Zhivotovsky B, Pokrovskaja K, Sangfelt O, Castro J, Einhorn S, Grandér D. Mechanisms of interferon-alpha induced apoptosis in malignant cells. Oncogene. 2002;21(8):1251-62.